Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 47,312	$ 46,339
Short-term investments	134,229	150,917
Accounts receivable, net	28,900	11,804
Inventory	28,892	27,886
Prepaid expenses and other current assets	34,404	31,360
Total current assets	273,737	268,306
Restricted cash	739
Long-term investments	16,681	5,482
Property and equipment, net	83,781	85,365
Goodwill	1,931	1,931
Other intangible assets	5,217	5,265
Other assets	28,055	26,757
Total assets	410,141	393,843
Current liabilities:
Accounts payable	5,041	6,792
Accrued expenses and other current liabilities	40,103	40,293
Senior convertible notes - current	36,109
Liability for sale of future royalties - current	12,802	12,283
Financing liability - current	10,125	10,062
Deferred revenue — current	11,757	12,407
Total current liabilities	115,937	81,837
Liability for sale of future royalties - long term	137,420	137,362
Financing liability - long term	93,665	93,877
Deferred revenue — long term	47,360	51,160
Recognized loss on purchase commitments — long term	60,713	58,204
Operating lease liability	11,141	11,645
Milestone liabilities	2,523	2,523
Senior convertible notes		36,051
Total liabilities	468,759	472,659
Commitments and contingencies (Note 14)
Stockholders' deficit:
Undesignated preferred stock, $0.01 par value - 10,000,000 shares authorized; no shares issued or outstanding as of March 31, 2025 or December 31, 2024
Common stock, $0.01 par value - 800,000,000 shares authorized; 303,918,969 and 302,959,782 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	3,039	3,029
Additional paid-in capital	3,125,830	3,118,865
Accumulated other comprehensive income	1,174	1,109
Accumulated deficit	(3,188,661)	(3,201,819)
Total stockholders' deficit	(58,618)	(78,816)
Total liabilities and stockholders' deficit	$ 410,141	$ 393,843